Leech Collagenase
ECM-degrading enzyme — facilitates spread of salivary compounds at the bite site.
- Hementerin80 kDa
- Hementin80 kDa
- Hementin-Like Protein (HLP-1)80 kDa
- Leech Collagenase70 kDa
- Haemadipsa yanyuanensis Progranulin (Hy-PGRN)70 kDa
- Leech Apyrase67 kDa
- Calin65 kDa
- Hyaluronidase60 kDa
- Antithrombin III binding protein58 kDa
- Collagenolytic Fibrinolysin55 kDa
- Leech Thrombospondin-Like Protein50 kDa
- LHyal (Leech Hyaluronidase)50 kDa
Mechanistic Evidence Box
Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.- Page type
- Compound profile
- Evidence type
- Preclinical / biochemical characterization
- Evidence level
- Mechanistic discussion
- Drug vs leech
- Leech-derived crude extract
Clinical translation limit
Leech collagenase is a mechanistic 'spreading factor' description, not a characterized clinical drug. Distinct from FDA-approved bacterial-derived collagenase products (e.g., Santyl, Xiaflex) which are unrelated commercial enzymes. No leech-derived collagenase is FDA-approved.
Molecular Profile
- Category
- ECM Enzyme
- Evidence tier
- Preclinical
- Molecular weight
- 70,000 Da
- Source species
- Hirudo medicinalis
Biological Targets
- → interstitial collagen (Type I, III)
External Resources
Related ECM Enzyme Compounds
Hyaluronidase
Enzyme that degrades hyaluronic acid in extracellular matrix — 'spreading factor' enhancing diffusion of other SGS compounds.
LHyal (Leech Hyaluronidase)
Hyperactive Hirudo medicinalis hyaluronate hydrolase used for HA oligosaccharide industrial production — Liao 2023 yeast-surface-display recombinant biocatalyst.